ReShape Lifesciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Oct 23 | Sell€278 | Thomas Stankovich | Individual | 357 | €1.35 | |
11 Oct 23 | Sell€86 | Thomas Stankovich | Individual | 78 | €1.34 | |
06 Jul 23 | Sell€143 | Thomas Stankovich | Individual | 106 | €1.35 |
Insider Trading Volume
Insider Buying: 24O insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 16,695 | 3.45% |
Individual Insiders | 18,510 | 3.83% |
Hedge Funds | 47,851 | 9.9% |
General Public | 400,472 | 82.8% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 35.9%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
47,851 | €346.6k | 1,570% | 0.01% | |||
8,850 | €64.1k | -42.8% | no data | |||
6,171 | €44.7k | 62.2% | no data | |||
6,132 | €44.4k | 2.94% | no data | |||
2,649 | €19.2k | 0% | no data | |||
2,372 | €17.2k | -76.5% | no data | |||
1,117 | €8.1k | 0% | no data | |||
1,043 | €7.6k | 0% | no data | |||
840 | €6.1k | 0.12% | no data | |||
741 | €5.4k | 0% | no data | |||
722 | €5.2k | -78.9% | no data | |||
668 | €4.8k | 0% | no data | |||
657 | €4.8k | -26.4% | no data | |||
644 | €4.7k | 1,330% | no data | |||
604 | €4.4k | -75% | no data | |||
414 | €3.0k | 0% | no data | |||
405 | €2.9k | 4.38% | no data | |||
286 | €2.1k | 0% | no data | |||
279 | €2.0k | 0% | no data | |||
215 | €1.6k | -57.9% | no data | |||
214 | €1.6k | 0% | no data | |||
75 | €543.2 | 7,400% | no data | |||
74 | €535.8 | 0% | no data | |||
25 | €181.1 | -79.2% | no data | |||
17 | €123.3 | 0% | no data |